Cytokinetics Inc

Common Name
Cytokinetics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
498
Ticker
CYTK
Exchange
NASDAQ/NGS
Description
Cytokinetics, Incorporated is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative muscle activators and inhibitors. Its primary mission is to ad...

Cytokinetics's GHG Emissions Data Preview

In 2023, Cytokinetics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, Cytokinetics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Cytokinetics's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Cytokinetics amounted to 1,230 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Cytokinetics decreased by 16.44%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

Cytokinetics's Scope 1 Emissions Over Time

202220230200400600800tCO2e-39%
  • Total Scope 1
  • Year-over-Year Change

What are Cytokinetics's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Cytokinetics were 391 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Compared to the previous year (2022), Cytokinetics's Scope 1 emissions decreased by 39.1%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are Cytokinetics's Scope 2 emissions?

In 2023, Cytokinetics reported Scope 2 greenhouse gas (GHG) emissions of 839 tCOâ‚‚e without specifying the calculation method.

Has Cytokinetics reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Cytokinetics's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Cytokinetics 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does Cytokinetics use for Scope 2 reporting?

In 2023, Cytokinetics reported its Scope 2 emissions using an unspecified methodology.

Cytokinetics's Scope 2 Emissions Over Time

2022202302505007501 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)
Want Full Access to Cytokinetics's GHG Emissions Dataset?
Sign Up